Characterizing invading glioma cells based on IDH1-R132H and Ki-67 immunofluorescence
- 3 January 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Brain Tumor Pathology
- Vol. 31 (4), 242-246
- https://doi.org/10.1007/s10014-013-0172-y
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric gliomaAnnals of Diagnostic Pathology, 2012
- Receptor Tyrosine Kinases: Principles and Functions in Glioma InvasionAdvances in experimental medicine and biology, 2012
- Clinicopathological features of human brainstem gliomasBrain Tumor Pathology, 2012
- Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosisActa Neuropathologica, 2010
- The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patientsJournal of Neuro-Oncology, 2009
- Monoclonal antibody specific for IDH1 R132H mutationActa Neuropathologica, 2009
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in GliomasJournal of Clinical Oncology, 2009
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Molecular targets of glioma invasionCellular and Molecular Life Sciences, 2007
- Dichotomy of astrocytoma migration and proliferationInternational Journal of Cancer, 1996